SCHEMBL2097977

SCHEMBL2097977

CCOC(=O)C(C)(C(=O)O)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.44
CYP4A11 Q02928 3/20 0.44
ALDH1A1 P00352 3/20 0.43
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 3/20 0.41
MMP8 P22894 2/20 0.41
PIN1 Q13526 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
THRB P10828 1/20 0.39
ABCB11 O95342 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27691346 0.95 CYP4F2 (0.44) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
SCHEMBL2097284 0.91 PKM (0.41) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
SCHEMBL2036323 0.87 ALDH1A1 (0.50) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
SCHEMBL8849154 0.83 ALDH1A1 (0.42) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
SCHEMBL1561661 0.80 CYP4F2 (0.44) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
SCHEMBL1299895 0.80 CYP4F2 (0.44) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
Hydrochloric Acid SCHEMBL11066122 0.78 CYP4F2 (0.42) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
SCHEMBL29214070 0.78 CYP4F2 (0.42) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
Lithium SCHEMBL30945444 0.78 CYP4F2 (0.42) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10
Ammonia Solution, Strong SCHEMBL11065651 0.78 CYP4F2 (0.42) CYP4F2CYP4A11ALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372300-B2 Additives for electrolyte solution and electrolyte solution OTSUKA CHEMICAL CO., LTD. (JP) 2013-02-12 US claimed
EP-2037468-B1 ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION OTSUKA CHEMICAL CO LTD (JP) 2012-10-24 EP claimed
US-20120170172-A1 ADDITIVES FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION OKA AKINORI (JP) 2012-07-05 US claimed
US-8163195-B2 Additives for electrolyte solution and electrolyte solution OTSUKA CHEMICAL CO., LTD. (JP) 2012-04-24 US claimed
US-20090309060-A1 Additives for Electrolyte Solution and Electrolyte Solution OTSUKA CHEMICAL CO., LTD. (JP) 2009-12-17 US claimed
CN-101479818-A Additive for electrolyte and electrolyte OTSUKA CHEMICAL CO LTD (JP) 2009-07-08 CN claimed
EP-2037468-A1 ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION Otsuka Chemical Co., Ltd. (JP) 2009-03-18 EP claimed
US-8372300-B2 Additives for electrolyte solution and electrolyte solution OTSUKA CHEMICAL CO., LTD. (JP) 2013-02-12 US disclosed
EP-2037468-B1 ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION OTSUKA CHEMICAL CO LTD (JP) 2012-10-24 EP disclosed
CN-101479818-B Additive for electrolyte and electrolyte OTSUKA CHEMICAL CO LTD 2012-10-17 CN disclosed
US-20120170172-A1 ADDITIVES FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION OKA AKINORI (JP) 2012-07-05 US disclosed
US-8163195-B2 Additives for electrolyte solution and electrolyte solution OTSUKA CHEMICAL CO., LTD. (JP) 2012-04-24 US disclosed
US-20090309060-A1 Additives for Electrolyte Solution and Electrolyte Solution OTSUKA CHEMICAL CO., LTD. (JP) 2009-12-17 US disclosed
CN-101479818-A Additive for electrolyte and electrolyte OTSUKA CHEMICAL CO LTD (JP) 2009-07-08 CN disclosed
EP-2037468-A1 ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION Otsuka Chemical Co., Ltd. (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090309060-A1 Additives for Electrolyte Solution and Electrolyte Solution SLC9A1, SLC26A3, AQP1 CYP4F2 2459/4885CYP4A11 1457/4885ALDH1A1 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.